Skip to main content

Synthase Biotech

Hamilton, New Zealand

Synthase Biotech aim to develop, manufacture, supply welldesigned high quality life-extension enzyme technologies for the benefit of humans.

$6K raised
Sep 2022
Grant

Top Investors

Callaghan InnovationEnterprise AngelsIce AngelsNew Zealand Venture Investment FundMatū Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Synthase Biotech

How much funding has Synthase Biotech raised?
Synthase Biotech has raised $6K in total funding. The most recent round was Grant. The last funding was announced in September 2022.
Who are Synthase Biotech's investors?
Synthase Biotech's investors include Callaghan Innovation, Enterprise Angels, Ice Angels, New Zealand Venture Investment Fund, Matū Group.
Where is Synthase Biotech headquartered?
Synthase Biotech is headquartered in Hamilton, New Zealand.
What does Synthase Biotech do?
Synthase Biotech aim to develop, manufacture, supply welldesigned high quality life-extension enzyme technologies for the benefit of humans.
What stage is Synthase Biotech at?
Synthase Biotech is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Synthase Biotech — Funding & Investors." VCBacked, September 15, 2022, https://www.vcbacked.co/company/synthase-biotech. Accessed July 1, 2026.
APA
VCBacked. (2022). Synthase Biotech — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/synthase-biotech
Wikipedia (cite web)
{{cite web |title=Synthase Biotech — Funding & Investors |url=https://www.vcbacked.co/company/synthase-biotech |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .